| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Erlotinib Hydrochloride | FAERS: 9 | US FAERS | |
| 2 | Erlotinib Hydrochloride | FAERS: 8 | US FAERS | |
| 3 | pazopanib | FAERS: 4 | US FAERS | |
| 4 | Everolimus | FAERS: 2 | US FAERS | |
| 5 | Octreotide | FAERS: 2 | US FAERS | |
| 6 | Sorafenib | FAERS: 2 | US FAERS | |
| 7 | Atorvastatin | FAERS: 1 | US FAERS | |
| 8 | Clozapine | FAERS: 1 | US FAERS | |
| 9 | Ezetimibe | FAERS: 1 | US FAERS | |
| 10 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 11 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 12 | Thalidomide | FAERS: 1 | US FAERS | |
| 13 | olaparib | FAERS: 1 | US FAERS | |
| 14 | osimertinib | FAERS: 1 | US FAERS | |
| 15 | Amiloride | OFFSIDES | ||
| 16 | Aripiprazole | OFFSIDES | ||
| 17 | Beclomethasone | OFFSIDES | ||
| 18 | Bisacodyl | OFFSIDES | ||
| 19 | Bleomycin | OFFSIDES | ||
| 20 | Bupropion | OFFSIDES | ||
| 21 | Chlorhexidine | OFFSIDES | ||
| 22 | Cortisone | OFFSIDES | ||
| 23 | Cortisone | OFFSIDES | ||
| 24 | Diphenoxylate | OFFSIDES | ||
| 25 | Doxepin | OFFSIDES | ||
| 26 | Doxycycline | OFFSIDES | ||
| 27 | Etoposide | OFFSIDES | ||
| 28 | Fluconazole | OFFSIDES | ||
| 29 | Fulvestrant | OFFSIDES | ||
| 30 | Irinotecan | OFFSIDES | ||
| 31 | Letrozole | OFFSIDES | ||
| 32 | Medroxyprogesterone | OFFSIDES | ||
| 33 | Modafinil | OFFSIDES | ||
| 34 | Octreotide | OFFSIDES | ||
| 35 | Paroxetine | OFFSIDES | ||
| 36 | Tamoxifen | OFFSIDES | ||
| 37 | Tetracycline | OFFSIDES | ||
| 38 | Ubiquinone | OFFSIDES | ||
| 39 | Zoledronic Acid | OFFSIDES | ||
| 40 | brinzolamide | OFFSIDES | ||
| 41 | chlorhexidine gluconate | OFFSIDES | ||
| 42 | regorafenib | Canada Vigilance: 1 | Canada Vigilance | |
| 43 | samarium Sm-153 lexidronam | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.